Lidocaine/prilocaine - Plethora Solutions

Alternative Names: Fortacin; Prilocaine Lidocaine Plethora; Prilocaine/lidocaine; PSD-502; Tempe

Latest Information Update: 04 Feb 2019

Price : $50 ^*

* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

Originator Plethora Solutions
Class Acetanilides; Anilides; Erectile dysfunction therapies; Local anaesthetics; Small molecules
Mechanism of Action Sodium channel antagonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No
Available For Licensing Yes

Highest Development Phases

Marketed Premature ejaculation
Discontinued Pain

Most Recent Events

04 Feb 2019 Chemical structure information added
17 Dec 2018 Plethora Solutions initiates a phase II trial for Premature ejaculation in USA (Topical) (NCT03578783)
06 Jul 2018 Plethora Solutions plans a phase II trial for Premature ejaculation in USA (Topical) (NCT03578783)

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login with a username/password associated to an account with a valid subscription
Contact your organization’s admin about adding this content to your AdisInsight subscription
Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Welcome to AdisInsight